Regeneron Pharmaceuticals (REGN) News Today → [Shocking] Elon Musk’s Plan To End Banks (From Crypto 101 Media) (Ad) Free Regn Stock Alerts $900.16 +3.34 (+0.37%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineLoring Wolcott & Coolidge Fiduciary Advisors LLP MA Buys 17,529 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 22 at 11:39 PMRegeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)globenewswire.com - April 22 at 5:54 PMShikiar Asset Management Inc. Cuts Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 21 at 5:00 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Shares Gap Up to $893.99americanbankingnews.com - April 21 at 1:42 AMabrdn plc Buys 186,215 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 20 at 12:10 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Lowered to Buy at StockNews.comamericanbankingnews.com - April 20 at 2:18 AMRegeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Cautionfinance.yahoo.com - April 19 at 12:59 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Lifted by Xponance Inc.marketbeat.com - April 19 at 10:17 AMUBS Group Increases Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,099.00americanbankingnews.com - April 19 at 2:36 AMRegeneron Pharmaceuticals (NASDAQ:REGN) and Oragenics (NYSE:OGEN) Critical Reviewamericanbankingnews.com - April 18 at 1:14 AMThe Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investorsbusinesswire.com - April 17 at 2:15 PMCantor Fitzgerald Reaffirms Their Hold Rating on Regeneron (REGN)markets.businessinsider.com - April 17 at 1:28 PMIf You Invested $100 In This Stock 20 Years Ago, You Would Have $6,700 Todaybenzinga.com - April 17 at 1:28 PMVontobel Holding Ltd. Has $6.24 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 17 at 6:18 AMRegeneron to “vigorously defend” against DOJ on Eylea pricing complaintmsn.com - April 16 at 8:37 PMHealthInvest Partners AB Invests $3.50 Million in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 16 at 6:50 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Receives "Neutral" Rating from Cantor Fitzgeraldamericanbankingnews.com - April 16 at 4:04 AMRegeneron to defend against DOJ complaint on drug-price manipulationfinance.yahoo.com - April 15 at 11:56 PMUPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulationfinance.yahoo.com - April 15 at 11:56 PMRegeneron to defend US Justice Department's complaint on drug-pricing manipulationreuters.com - April 15 at 7:24 PMCantor Fitzgerald Reaffirms "Neutral" Rating for Regeneron Pharmaceuticals (NASDAQ:REGN)marketbeat.com - April 15 at 3:31 PMSumitomo Mitsui Trust Holdings Inc. Has $280.48 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 15 at 8:44 AMBank of America Boosts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $720.00americanbankingnews.com - April 14 at 5:14 AMRegeneron Pharmaceuticals (NASDAQ:REGN) Lifted to "Strong-Buy" at StockNews.comamericanbankingnews.com - April 14 at 1:44 AMMn Services Vermogensbeheer B.V. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 13 at 7:31 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Trading Down 2.6%americanbankingnews.com - April 13 at 6:00 AMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Consensus Rating of "Moderate Buy" from Analystsamericanbankingnews.com - April 13 at 2:30 AMRegeneron Pharmaceuticals (NASDAQ:REGN) Lifted to Strong-Buy at StockNews.commarketbeat.com - April 12 at 11:17 PMNewEdge Wealth LLC Raises Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 12 at 9:03 PMAnalysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Regeneron (REGN)markets.businessinsider.com - April 12 at 12:47 PMBreaking Down Regeneron Pharmaceuticals: 13 Analysts Share Their Viewsmarkets.businessinsider.com - April 12 at 12:47 PMBank of America Raises Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $720.00marketbeat.com - April 12 at 8:27 AMEye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drugmsn.com - April 11 at 3:54 PMAre Regeneron's Legal Troubles — And Six-Week Slide — A Buying Opportunity?investors.com - April 11 at 1:01 PMRegeneron Pharmaceuticals (NASDAQ:REGN) Shares Down 2.6% marketbeat.com - April 11 at 12:45 PMUS accuses Regeneron of fraudulent price reporting for eye drugmsn.com - April 11 at 10:32 AMThese Stocks Are Moving the Most Today: CarMax, Fastenal, Alpine Immune, Nike, Robinhood, Constellation Brands, and Morefinance.yahoo.com - April 11 at 10:32 AMDow Jones Lower Despite PPI Inflation Relief; Nvidia, Microsoft Price Targets Raisedfinance.yahoo.com - April 11 at 10:32 AMRegeneron Stock Under Microscope After DOJ Price Reporting Complaint—Key Levels to Watchinvestopedia.com - April 11 at 8:25 AMRegeneron Pharma falls after US government alleges fraudproactiveinvestors.com - April 11 at 7:48 AMRegeneron accused of ‘fraudulent’ drug-pricing reporting for eye drug Eyleamarketwatch.com - April 10 at 6:18 PMUPDATE 1-US Justice department files complaint against Regeneron, alleges fraudulent drug pricingfinance.yahoo.com - April 10 at 6:18 PMUS Justice department files complaint against Regeneron, alleges fraudulent drug pricingfinance.yahoo.com - April 10 at 6:18 PMUS Justice department files complaint against Regeneron, alleges fraudulent drug pricingreuters.com - April 10 at 4:59 PMAn Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 47% Undervaluedfinance.yahoo.com - April 10 at 1:17 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Plimoth Trust Co. LLCmarketbeat.com - April 9 at 9:26 PMTrifecta Capital Advisors LLC Has $2.23 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 8 at 5:11 PMLinvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myelomaglobenewswire.com - April 7 at 4:00 PMDekaBank Deutsche Girozentrale Boosts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 7 at 10:12 AMTamar Securities LLC Raises Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)marketbeat.com - April 6 at 5:41 PM Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address [Shocking] Elon Musk’s Plan To End Banks (Ad)Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030. Click here now to get your copy. REGN Media Mentions By Week REGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REGN News Sentiment▼0.660.47▲Average Medical News Sentiment REGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REGN Articles This Week▼2014▲REGN Articles Average Week Get Regeneron Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for REGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vertex Pharmaceuticals News Bristol-Myers Squibb News Sanofi News GSK News Zoetis News Takeda Pharmaceutical News Royalty Pharma News Abbott Laboratories News BeiGene News Catalent News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REGN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
